- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/40 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
Patent holdings for IPC class A61K 39/40
Total number of patents in this class: 954
10-year publication summary
|
81
|
80
|
55
|
82
|
67
|
50
|
40
|
38
|
32
|
5
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| MedImmune, LLC | 467 |
25 |
| Xencor, Inc. | 403 |
25 |
| New York University | 1635 |
15 |
| The Regents of the University of California | 18943 |
14 |
| MacroGenics, Inc. | 267 |
13 |
| The University of Chicago | 1282 |
13 |
| Research Institute at Nationwide Children's Hospital | 481 |
11 |
| Novartis AG | 11238 |
9 |
| Board of Regents, The University of Texas System | 5370 |
9 |
| Abbvie Inc. | 1808 |
9 |
| Humabs Biomed SA | 115 |
9 |
| Merus N.V. | 185 |
9 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
9 |
| University of Maryland, Baltimore | 999 |
9 |
| Glaxosmithkline Biologicals S.A. | 1701 |
8 |
| The Regents of the University of Michigan | 4409 |
8 |
| E. R. Squibb & Sons, L.L.C. | 130 |
8 |
| MedImmune Limited | 627 |
8 |
| University of Rochester | 1243 |
8 |
| Camas Incorporated | 26 |
7 |
| Other owners | 728 |